Detalles de la búsqueda
1.
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma.
Mod Pathol
; 36(5): 100154, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36925069
2.
Combined exercise intervention in a mouse model of high-risk neuroblastoma: effects on physical, immune, tumor and clinical outcomes.
Exerc Immunol Rev
; 29: 86-110, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358366
3.
Deregulation of the miR-19b/PPP2R5E Signaling Axis Shows High Functional Impact in Colorectal Cancer Cells.
Int J Mol Sci
; 24(9)2023 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37175484
4.
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.
Int J Mol Sci
; 24(4)2023 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36835014
5.
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.
Int J Mol Sci
; 25(1)2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203378
6.
Clinical and economic impact of 'ROS1-testing' strategy compared to a 'no-ROS1-testing' strategy in advanced NSCLC in Spain.
BMC Cancer
; 22(1): 292, 2022 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303812
7.
MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.
Int J Mol Sci
; 23(20)2022 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36293302
8.
MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients.
Int J Mol Sci
; 23(4)2022 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216319
9.
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.
Int J Mol Sci
; 23(21)2022 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362083
10.
Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario.
BMC Cancer
; 21(1): 689, 2021 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34112097
11.
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion.
Future Oncol
; 17(10): 1209-1218, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33289433
12.
A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report.
Int J Mol Sci
; 22(14)2021 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34299133
13.
Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer.
Int J Mol Sci
; 22(24)2021 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34948097
14.
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain.
Oncologist
; 25(9): e1339-e1345, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32652782
15.
PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implications.
Biochim Biophys Acta Rev Cancer
; 1868(2): 435-438, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28916342
16.
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Semin Cancer Biol
; 52(Pt 2): 16-25, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024776
17.
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02).
Oncologist
; 24(11): e1115-e1122, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31235483
18.
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.
Breast Cancer Res Treat
; 178(2): 251-261, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31388936
19.
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
Breast Cancer Res Treat
; 176(2): 377-386, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31041683
20.
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Breast Cancer Res Treat
; 174(3): 693-701, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30607629